| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040093623 Non-human animal disease models |
| 05/13/2004 | US20040093622 Preparing transgenic rodent expressing genetically engineered immunoglobulins for treatment hypercholesterolemia, atherosclerosis, cystic fibrosis and muscular dystrophy |
| 05/13/2004 | US20040092016 Enhanced homologous recombination mediated by lambda recombination proteins |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091913 Composition and method for imaging cells |
| 05/13/2004 | US20040091898 Polynucleotide sequence encoding phosphatidylinositol(PI3k) protein; useful in reducing cell death after trauma and overcoming insulin resistance |
| 05/13/2004 | US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models |
| 05/13/2004 | US20040089241 Rearing fly larvae and animals in space for waste recycling and food supplying |
| 05/13/2004 | CA2502839A1 Method of using animal models to predict adverse drug reactions |
| 05/13/2004 | CA2411729A1 Knock-in mouse prostate cancer model |
| 05/12/2004 | EP1418571A1 Voice connection system between humans and animals |
| 05/12/2004 | EP1418185A1 Use of EDG2 receptor in an animal model of heart failure |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1417485A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417338A1 Genes and snps associated with eating disorders |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1416791A2 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy |
| 05/12/2004 | EP1416790A1 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same |
| 05/12/2004 | EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals |
| 05/12/2004 | CN1495195A Transgenic animal for expressing androgen receptor compound relatea protein |
| 05/12/2004 | CN1494824A Cattle directional lemale-male breeding method solution |
| 05/12/2004 | CN1149013C Method for large scale cultivation of fly maggot and deivce thereof |
| 05/11/2004 | US6734338 Using composition for in vitro and in vivo transfection of vertebrate male germ cells comprising a nucleic acid or transgene and a gene delivery system, and optionally a protective internalizing agent |
| 05/11/2004 | US6734336 Useful in identifying compounds for treating alzheimer's disease |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/06/2004 | WO2004037975A2 Composition and method for imaging cells |
| 05/06/2004 | WO2004037849A2 Transgenic non-human animals with expanded mature b cell and plasma cell populations |
| 05/06/2004 | WO2004036982A2 Shrimp and the production thereof |
| 05/06/2004 | WO2004011676A3 Multi-reporter gene model for toxicological screening |
| 05/06/2004 | WO2003100028A3 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003093414A3 Transgenic animal model for spliceosome-mediated rna trans-splicing |
| 05/06/2004 | WO2003050502A9 Prospective identification and characterization of breast cancer stem cells |
| 05/06/2004 | WO2003024200A8 Production of transgenic birds using stage x primordial germ cells |
| 05/06/2004 | WO2003019197A3 Diabetic model |
| 05/06/2004 | WO2002072017A9 Method of drug target validation |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | US20040088748 Method of performing transgenesis |
| 05/06/2004 | US20040088747 Growth differentiation factor-11 |
| 05/06/2004 | US20040088745 Using expression vector coding heterologous gene associated with sex determination to generate animal models of preferential sex; veterinary medicine; animal husbandry; in vitro fertilization |
| 05/06/2004 | US20040088743 Non-human transgenic animal expressing ca-ahr |
| 05/06/2004 | US20040088164 Voice connection system between humans and animals |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040086893 Gab2 (p97) gene and methods of use thereof |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | EP1416272A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson's disease |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1415160A2 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 05/06/2004 | EP1415154A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 05/06/2004 | EP1414965A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/06/2004 | EP1414959A1 Delivery of dsrna to arthropods |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414851A2 Cellular virus receptors and methods of use. |
| 05/06/2004 | EP1414478A2 Inhibition of neurodegeneration |
| 05/05/2004 | CN2613996Y Equipment for cultivating sea cucumber in room |
| 05/05/2004 | CN1148118C Enclosure method of preventing pale spot of prawn as one virosis |
| 05/05/2004 | CN1148117C Automatic or semiautomatic industrial cultivation of forest frog |
| 05/05/2004 | CN1148115C Gametophyte cloning method of breeding heterotic kelp |
| 05/04/2004 | US6730822 For introduction and expression of exogenous genetic material in eggs; making exogenous interferon-alpha and erythrpoietin |
| 05/04/2004 | US6730512 Combination immunogene therapy |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730023 Animal genetic and health profile database management |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 04/29/2004 | WO2004035787A2 Transplantable cell with immune modulator |
| 04/29/2004 | WO2004035782A2 Sirna mediated gene silencing in transgenic animals |
| 04/29/2004 | WO2004035775A2 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 04/29/2004 | WO2004035509A1 Apparatus for use in vermiculture |
| 04/29/2004 | WO2004035082A2 Proteins involved in the regulation of energy homeostasis |
| 04/29/2004 | WO2004034778A2 Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same |
| 04/29/2004 | WO2004015107A3 Further novel forms of interfering rna molecules |
| 04/29/2004 | WO2003087408A3 Schizophrenia associated genes |
| 04/29/2004 | WO2003087341A3 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 04/29/2004 | WO2003060087A3 Rapid method of selecting cells for gene disruption by homologous recombination |
| 04/29/2004 | WO2003054170A8 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2502664A1 Sirna mediated gene silencing in transgenic animals |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2501340A1 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1411974A2 Materials and methods relating to improved vaccination strategies |
| 04/28/2004 | EP1411856A2 Apparatus for detecting estrus in livestock |
| 04/28/2004 | EP1411825A2 Animal healthcare, well-being and nutrition |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | CN1492927A Human FGF23 protein mutant lowering blood phosphorus level |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/28/2004 | CN1147223C Method for southward propagating and raising Chinese wood frog |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | CA2152047C Production of human recombinant collagen in the milk of transgenic animals |
| 04/22/2004 | WO2004033640A2 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |